Profacgen, a leader in the area of protein research tool supply, recently enlarged its Drug Screening Services scope. Now it offers GPCR Screening Service, Ion Channel Screening Service, Transporter Screening Service, and Protein Activator Inhibitor Screening Service to meet its Customers’ needs for drug development.
Profacgen has developed a large collection of screening panels covering all kinds of GPCRs. The company can do rapid profiling of its customers’ compounds against a panel of GPCRs, or perform in-depth EC50/IC50 determinations. It can also provide custom GPCR screening assay based on preliminary data, i.e., GPCR agonist screening, GPCR antagonist screening, GPCR allosteric modulator screening, GPCR inverse agonist screening, etc.
For Ion Channel Screening Service, Profacgen has developed a long list of ion channel assay models with efficient signal read-out and good stability. It provides a comprehensive package of service from ion channel screening, active/inhibitory compound validation, and specificity analysis to electrophysiology detection.
For Transporter Screening Service, Profacgen offers transporter targets that have great significance in preclinical study, including ATP binding cassette transporter (P-gp), neurotransmitter (SERT, DAT, NET), and solution carrier family transporter (SLC13). Its assay methods include radio-isotopic detection, fluorescence detection and ion flux detection.
For Protein Activator Inhibitor Screening Service, Profacgen has developed a highly efficient screening system to select candidates by the detection of fluorescence, chemo-luminescence or isotopic signal.
“We are quite excited for the launch of drug screening services for our customers. We do believe those novel services can help promote our customers’ drug development process.” Commented Crystal, the chief marketing staff in Profacgen.
To know more information about Drug Screening Services in Profacgen, please visit: https://www.profacgen.com.
Profacgen provides process development and cGMP manufacturing services for biological active ingredients. We have ready access to state-of-the-art biopharmaceutical product development and manufacturing facilities and our staff scientists have demonstrable expertise in all aspects of biopharmaceutical manufacturing, from facility design and operation to the ability to provide best advice relating to product development. We also save our clients a great deal of time with bioprocess scale-up services. Our fermentation laboratories are equipped with state-of-the-art fermentors and bioreactors that enable us to express protein in large scale. Our customers can choose to enter into the protein expression pipeline at any stage depending on their needs.
Company Name: Profacgen
Contact Person: Ellen Burns
Address:45-1 Ramsey Road
State: New York
Country: United States